Clinical Decision Support for Pharmacogenomic Precision Medicine

Clinical Decision Support for Pharmacogenomic Precision Medicine :Foundations and Implementation

paperback
Published: 20 June, 2022
Standard worldwide delivery by Tue, August 4 - Fri, August 7
Order within 0
Condition: NEW
$141.99
RRP $180.98
You save $38.98 (22%)
Price includes shipping
Available 20 in stock
- +
FREE Returns within 30 days

Description

Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation offers overviews, methods and strategies for translating genomic medicine to clinical practice. The book's authors explore incorporating pharmacogenetics into electronic health records, CDS methods and infrastructure for delivery, economic evaluation, the hospital administrations’ role and needs in integration, and patient counseling aspects. The book empowers clinicians, researchers, translational scientists, and data and IT experts to effectively navigate the complex landscape of CDS for pharmacogenomic precision medicine. Illustrative case studies of existing gene networks include CSER, eMERGE, the IGNITE network, DIGITIZE, the CDS Learning Network (RTI), ClinGen, Ubiquitous and CDS Hooks.
See more

More Details

Type Book
ISBN13 9780128244531
ISBN10 0128244534
Number Of Pages 296
Item Weight 480 g
Publisher / Reseller Elsevier Science Publishing Co Inc
Format paperback
See More +

Author's Bio

Beth Devine is Research Assistant Professor in The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute; Formerly Pharmaceutical, Outcomes Research and Policy Program (PORPP), Department of Pharmacy, University of Washington, USA. Dr. Richard D. Boyce is an Assistant Professor of Biomedical Informatics in the University of Pittsburgh School of Medicine. His research studies the use of informatics and pharmacoepidemiology to support safe and effective medication therapy for older adults. He has published more than a dozen peer-reviewed papers including a systematic review of the effectiveness of antidepressants for nursing home residents, a review of pharmacokinetic drug interactions affecting antidepressants, a study concordance between various sources of psychotropic drug-drug interaction information, and a pilot study of an innovation to enhance drug product label information on drug safety, efficacy. His current research studies active monitoring interventions for patient exposed to drug-drug interactions in the nursing home, and a how to best present clinical pharmacogenomics statements to clinicians and patients.

Show more